Characterization of α-isopropylmalate synthases containing different copy numbers of tandem repeats in Mycobacterium tuberculosis by Yindeeyoungyeon, Wandee et al.
BioMed  Central
Page 1 of 10
(page number not for citation purposes)
BMC Microbiology
Open Access Research article
Characterization of α-isopropylmalate synthases containing 
different copy numbers of tandem repeats in Mycobacterium 
tuberculosis
Wandee Yindeeyoungyeon*1, Supaporn Likitvivatanavong2 and 
Prasit Palittapongarnpim1,2
Address: 1National Center for Genetic Engineering and Biotechnology, NSTDA, Pathumthani 12120, Thailand and 2Department of Microbiology, 
Mahidol University, Bangkok 10400, Thailand
Email: Wandee Yindeeyoungyeon* - wandee@biotec.or.th; Supaporn Likitvivatanavong - spplikit@gmail.com; 
Prasit Palittapongarnpim - prasit@nstda.or.th
* Corresponding author    
Abstract
Background: Alpha-isopropylmalate synthase (α-IPMS) is the key enzyme that catalyzes the first
committed step in the leucine biosynthetic pathway. The gene encoding α-IPMS in Mycobacterium
tuberculosis, leuA, is polymorphic due to the insertion of 57-bp repeat units referred to as Variable
Number of Tandem Repeats (VNTR). The role of the VNTR found within the M. tuberculosis
genome is unclear. To investigate the role of the VNTR in leuA, we compared two α-IPMS proteins
with different numbers of amino acid repeats, one with two copies and the other with 14 copies.
We have cloned leuA with 14 copies of the repeat units into the pET15b expression vector with a
His6-tag at the N-terminus, as was previously done for the leuA gene with two copies of the repeat
units.
Results: The recombinant His6-α-IPMS proteins with two and 14 copies (α-IPMS-2CR and α-
IPMS-14CR, respectively) of the repeat units were purified by immobilized metal ion affinity
chromatography and gel filtration. Both enzymes were found to be dimers by gel filtration. Both
enzymes work well at pH values of 7–8.5 and temperatures of 37–42°C. However, α-IPMS-14CR
tolerates pH values and temperatures outside of this range better than α-IPMS-2CR does. α-IPMS-
14CR has higher affinity than α-IPMS-2CR for the two substrates, α-ketoisovalerate and acetyl
CoA. Furthermore, α-IPMS-2CR was feedback inhibited by the end product l-leucine, whereas α-
IPMS-14CR was not.
Conclusion:  The differences in the kinetic properties and the l-leucine feedback inhibition
between the two M. tuberculosis α-IPMS proteins containing low and high numbers of VNTR
indicate that a large VNTR insertion affects protein structure and function. Demonstration of l-
leucine binding to α-IPMS-14CR would confirm whether or not α-IPMS-14CR responds to end-
product feedback inhibition.
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Background
The biosynthesis pathways of the branched-chain amino
acids (valine, isoleucine and leucine) all begin with the
same precursors (pyruvate or pyruvate and 2-ketobu-
tyrate) and are catalyzed by acetohydroxy acid synthase
(AHAS; EC 4.1.3.8). The pathways that lead to valine and
isoleucine production have four common enzymatic
steps. Leucine biosynthesis via the isopropylmalate (IPM)
pathway branches from the valine biosynthesis pathway
with the conversion of 2-ketoisovalerate and acetyl CoA to
α-isopropylmalate. This first committed step of leucine
biosynthesis is catalyzed by α-isopropylmalate synthase
(α-IPMS; EC 4.1.3.12). The subsequent two steps are cat-
alyzed by isopropylmalate dehydratase and isopropyl-
malate dehydrogenase. The final step in the production of
leucine is catalyzed by an amino transferase enzyme. The
IPM pathway may be the primary metabolic route for pro-
ducing leucine in bacteria, as enzymes in this pathway
have been identified in diverse groups of bacteria [1]. The
key enzyme of this pathway, α-IPMS, has been isolated
and characterized in bacteria [2-4], fungi [5,6] and plants
[7,8]. A comparison of α-IPMS from different species
shows that there are significant sequence similarities, sug-
gesting that this enzyme is highly conserved [9].
The Mycobacterium tuberculosis genome contains several
types of repetitive DNA sequences, including an insertion
sequence (IS6110), Variable Number of Tandem Repeats
(VNTR) [10-13], mycobacterial interspersed repetitive
units (MIRU) [12], polymorphic GC-rich repetitive
sequences (PGRS) and direct repeats (DR) [14]. Although
the polymorphisms of these repetitive sequences have
been studied extensively, most of these studies were
focused on strain discrimination and epidemiological
studies of M. tuberculosis. At present, the role of VNTR in
M. tuberculosis is not well understood.
A VNTR locus, designated VNTR4155, has been found
within the coding region of the leuA gene. The locus con-
tains repeat units of 57 bp and an extra 9 bp and is poly-
morphic in various clinical isolates. Repeat units range
from 2–21 copies, and those with two copies are the most
abundant [15]. The leuA gene from most Beijing strains
and from the two completely sequenced virulent strains
H37Rv and CDC1551 contain two copies of 57-bp tan-
dem repeats. Since the repeats are multiples of 3 bp, a
deletion or insertion of 57 bp would not interfere with the
translational frame of the protein, but would be result in
the deletion or insertion of the repetitive 19-amino acid
residues. In fact, deletion of the two 57-bp repeat units
seemed to have no effect on the functionality of the
mutant α-IPMS compared to the wild-type α-IPMS. This
suggests that the repetitive 19-amino acid residues are dis-
pensable [16].
Previously, recombinant α-IPMS from M. tuberculosis
H37Rv was purified and characterized [4]. A recent inves-
tigation reported the kinetics of the enzyme with two cop-
ies of the repeat [17]. The three-dimensional crystal
structure of α-IPMS has also been solved and shows that
Zn2+ and α-KIV bind at the active site, while l-leucine (end
product of the pathway that exhibits feedback inhibition
to α-IPMS) binds at the regulatory region [18]. The feed-
back inhibition of α-IPMS by l-leucine is reversible and is
described as being a slow-onset inhibition. First, the bind-
ing of l-leucine to the enzyme substrate complex causes an
inhibitory signal that can be transmitted through the
linker domains. A slow isomerization step then occurs,
generating a more tightly bound form [19].
It has been shown that M. tuberculosis strains that have α-
IPMS with three, four and six copies of the repeat units
contain proteins of corresponding sizes that can be
detected by polyclonal antibodies against α-IPMS [4].
However, it is not known if the leuA from M. tuberculosis
strains that contain very higher numbers of the repeats is
translated into a full-length, intact protein with the same
activity. In this study, we have cloned, expressed and char-
acterized the products of the leuA genes with either two or
14 copies of VNTR. Our results indicate that some enzy-
matic properties of the recombinant His6-tagged α-IPMS
with 14 copies of repeats (α-IPMS-14CR) are different
from those with two copies (α-IPMS-2CR).
Results
Cloning and expression of the leuA gene with 14 copies of 
tandem repeats
The leuA gene from M. tuberculosis strain 731 contains 14
copies of the VNTR repeat unit and is 2619 bp long. The
amplification of leuA with the designed primers resulted
in PCR products of the predicted size, as shown in Figure
1. DNA sequencing confirmed the copy number of the 57-
bp repeat. The amplified DNA fragment of leuA with 14
copies of the VNTR repeat unit was cloned into the
pET15b expression vector with the N-terminus fused to
hexa-histidine (His6) in the same fashion as leuA from the
H37Rv strain, which contains two copies of the repeat
unit. The recombinant plasmids, designated p14C and
p2C, respectively, were expressed in E. coli BL21 (λDE3).
The sizes of α-IPMS-2CR and α-IPMS-14CR were the
expected sizes (74 and 99 kDa, respectively) of the full-
length proteins (Figure 2). We found that induction of
enzyme expression by IPTG at low temperature (20°C)
results in higher solubility than induction at 37°C. This
last condition was critical for α-IPMS-14CR, as it is
expressed to lower levels than α-IPMS-2CR. When
expressed at 37°C, almost all of the α-IPMS-14CR protein
aggregates (i.e., is associated with an insoluble fraction, as
assessed by SDS-PAGE (data not shown)).BMC Microbiology 2009, 9:122 http://www.biomedcentral.com/1471-2180/9/122
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Purification of His6-tagged proteins under native 
conditions
The purification of the His6-tagged proteins of α-IPMS-
2CR and α-IPMS-14CR under native conditions using a
Ni-NTA column yielded 90% and 80% pure protein,
respectively. These proteins were further purified by gel
filtration to approximately 99% purity. The yield of
recombinant protein per gram of cell wet weight was 0.4–
0.5 mg for α-IPMS-2CR and 0.1–0.2 mg for α-IPMS-14CR.
The oligomeric state of each recombinant protein, as sug-
gested by gel filtration analysis, was of a dimer (gel filtra-
tion profiles are presented in Additional file 1 and
Additional file 2). Although purified α-IPMS-2CR was
composed of both dimeric and tetrameric forms, the
majority of the protein is in present as a dimer. In addi-
tion, the enzymatic activity of the dimeric form was three
times higher than that of the tetrameric protein (data not
shown). The majority of purified α-IPMS-14CR was in
dimeric form, with enzymatic activity six times higher
than that of the minor fractions in monomeric form (data
not shown).
Enzymatic properties of His6-α-IPMS
Both  α-IPMS-2CR and α-IPMS-14CR enzymes worked
well at a pH between 7.5 and 8.5. At pH 9, α-IPMS-2CR
lost much of its activity, while the activity of α-IPMS-14CR
remained (Figure 3 panel A). The optimal temperature for
both enzymes was approximately 37–42°C. At 50°C, the
activity of α-IPMS-14CR remained at 75%, whereas the
activity of α-IPMS-2CR dropped below 50% (Figure 3
panel B).
The kinetic parameters of α-IPMS-2CR and α-IPMS-14CR
for both substrates are summarized in Table 1. The appar-
ent Km and Vmax of α-IPMS-2CR do not agree with those
reported previously (Km and Vmax for α-ketoisovaleric acid
was 24.6 μM and 0.8 U/mg, respectively; Km and Vmax for
acetyl CoA were 243.5 μM and 2.07 U/mg, respectively)
[4]. The reason for these discrepancies is unclear, but may
be at least partially due to differences in enzyme prepara-
tion and storage conditions. In the previous report, the
enzyme was maintained in an elution buffer containing
100–250 mM imidazol, while in this report, dialysis was
performed to eliminate imidazol from the enzyme solu-
tions and purified protein fractions obtained by gel filtra-
tion were used in the assays.
Comparison of the apparent Km/Vmax of α-IPMS-2CR and
α-IPMS-14CR, processed through similar conditions,
shows that α-IPMS-2CR has a lower affinity for its sub-
strates than α-IPMS-14CR (4-fold lower for α-ketoisova-
leric acid and 14-fold lower for acetyl CoA). The Vmax
values for both substrates of α-IPMS-2CR were higher
than those of α-IPMS-14CR, resulting in a higher kcat. α-
IPMS-14CR has a higher catalytic efficiency, however, as
kcat/Km ratios for α-ketoisovaleric acid and acetyl CoA
were approximately 2 and 5 times higher, respectively,
than those of α-IPMS-2CR. The l-leucine feedback inhibi-
tion of α-IPMS was investigated with the addition of 0.1
to 10.0 mM l-leucine to the enzyme assay mixtures. The
inhibition of α-IPMS-2CR was clearly detectable in the
presence of 0.4 mM l-leucine, and the enzyme was inhib-
ited by almost 50% with 0.8 mM l-leucine. l-leucine had
no significant effect on α-IPMS-14CR activity under simi-
lar assay conditions (Figure 4).
Discussion
The structure of the M. tuberculosis α-IPMS monomer (644
residues) consists of an N-terminal catalytic domain and
a C-terminal regulatory domain, which are linked by two
small subdomains. The N-terminal domain (residues 51–
368) forms an (α/β)8 TIM barrel that accommodates the
active site. Residues 1–50 function in dimerization. In the
PCR amplification of leuA genes from M. tuberculosis strains Figure 1
PCR amplification of leuA genes from M. tuberculosis 
strains. leuA genes were PCR amplified from H37Rv and 
Amnatchareon strain 731 with two and 14 copies of the tan-
dem repeats, respectively. Lane M, 200 bp DNA markers.
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Analysis of His6-α-IPMS proteins on SDS-PAGE Figure 2
Analysis of His6-α-IPMS proteins on SDS-PAGE. A) Crude protein extracts of E. coli BL21 harboring p2C (α-IPMS-2CR) 
and p14C (α-IPMS-14CR). Cells were grown overnight at 20°C without (-) or with (+) 0.5 mM IPTG. The cell pellets were 
sonicated, and the clear lysates were analyzed on 10% SDS-PAGE. Arrowheads indicate protein bands that were induced with 
IPTG. B) Purified His6-α-IPMS proteins from Ni-NTA agarose column. Lanes 1 and 2, elution fractions of His6-α-IPMS-14CR; 
Lane 3 and 4, elution fractions of His6-α-IPMS-2CR. MW, molecular weight markers.
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linker domain, subdomain I (residues 369–424) is com-
posed of α10 and two short β-strands, while subdomain
II (residues 434–490) contains α11-α13. The C-terminal
regulatory domain (residues 491–644) is composed of
two βββα units (β11, β12, β13, α14 and β14, β15, β16,
α15) [18]. The function of the repeat sequences within the
coding sequence of α-IPMS remains unclear, as this repeat
segment (corresponding to residues 575–612 in the C-ter-
minal domain, between β15 and β16) is disordered in the
crystal structure [18]. Singh and Bhakuni (2007) demon-
strated that although the isolated TIM barrel domain of α-
IPMS retains its folded conformation, it has only 12% of
the functional activity of the intact enzyme. This result
indicates that the C-terminus influences the activity of the
enzyme [20]. Here, we show that α-IPMS-2CR and α-
IPMS-14CR are both dimers in solution, as has been
observed previously with α-IPMS-2CR [4,17]. The differ-
ences between the two enzymes in their activities at high
pH and temperature and in some of their kinetic parame-
ters indicate that the copy number of the repeat unit does
affect the properties of the protein.
The optimal pH for both α-IPMS-2CR and α-IPMS-14CR
was between 7.5 and 8.5, similar to those in other organ-
isms. α-IPMS from S. typhimurium [2], S. cerevisiae [21],
Clostridium spp and Bacteroides fragilis [3] and Arabidopsis
[7] have optimal pHs of 8.5, 8.0, 8.0 and 8.5, respectively.
The optimal temperature for both α-IPMS-2CR and α-
IPMS-14CR enzymes was the same as the physiological
temperature of M. tuberculosis (37–42°C). Most previous
reports assayed enzymes at the physiological temperatures
of their respective organisms as well, e.g., 30°C for yeast
α-IPMS and 37°C for S. typhimuriumα-IPMS. The anaero-
bic bacteria Clostridium spp and Bacteroides fragilis have
higher optimal temperature for α-IPMS, ranging from 37–
46°C [3]. The apparent Km values for α-IPMS-2CR and α-
IPMS-14CR are different from those previously reported
[4,17]. A wide range of Km values for α-IPMS activity on α-
KIV and acetyl CoA have been reported in M. tuberculosis
Activities of His6-α-IPMS-2CR and His6-α-IPMS-14CR Figure 3
Activities of His6-α-IPMS-2CR and His6-α-IPMS-
14CR. Assays were performed as described in the Materials 
and Methods. Each point is the average of three assays and 
the vertical bars represent the standard deviations. A) Activi-
ties at various pH values at 37°C. B) Activities at various 
temperatures at pH 8.5.
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Table 1: Kinetic parameters, Vmax and Km, of α-IPMS reacting to α-ketoisovaleric acid and acetyl CoAa
α-IPMS α-Ketoisovaleric acid Acetyl CoA
Km
(μM)
Vmax
(U/mg protein)
R2 kcat
b
(s-1)
kcat/Km
(s-1 M-1)
Km
(μM)
Vmax
(U/mg protein)
R2 kcat
b
(s-1)
kcat/Km
(s-1 M-1)
α-IPMS-2CR 261
(S.E. = 14.7)
0.49
(S.E. = 0.01)
0.99 1.17 4480 568
(S.E. = 94.5)
0.93
(S.E. = 0.06)
0.99 2.22 3,900
α-IPMS-14CR 35
(S.E. = 5.4)
0.16
(S.E. = 0.01)
0.96 0.52 14,800 27
(S.E. = 6.9)
0.19
(S.E. = 0.01)
0.93 0.61 22,590
a At pH 8.5 and 37°C. The apparent Km and Vmax values were determined by varying the concentrations of one substrate at a fixed saturating 
concentration of the other substrate. α-ketoisovaleric acid and acetyl CoA was fixed at 2 mM and 0.8 mM, respectively. Data are the average of 
two assays. Prism software (version 3.08) was used for nonlinear regression, curve fit analysis to calculate Km and Vmax.
bkcat = Vmax/[E] (μmol s-1mg-1)/(mol mg-1)BMC Microbiology 2009, 9:122 http://www.biomedcentral.com/1471-2180/9/122
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[17], S. typhimurium [2] and S. cerevisiae [21] (12 and 136,
60 and 200, and 16 and 9 μM, respectively).
de Carvalho and Blanchard (2006) previously demon-
strated that the kinetic mechanism of α-IPMS in M. tuber-
culosis is a non-rapid, equilibrium random bi-bi and that
the chemistry is not a rate-limiting step in the overall reac-
tion. It was suggested that with physiological substrates,
slow substrate binding, product dissociation or conforma-
tional changes in the enzyme are likely to be the rate-lim-
iting step. This hypothesis is consistent with the fact that
α-IPMS-14CR has a lower Vmax relative to α-IPMS-2CR. α-
IPMS-14CR, with the additional 12 copies of the repeat
units, is ~30% larger than α-IPMS-2CR.
The lower Km (higher affinity for substrates) of α-IPMS-
14CR is more difficult to understand. A report on the cys-
tine protease CPB isoforms of Leishmania mexicana
showed that variation in a few charged amino acid resi-
dues located outside of but close to the active site may
influence the electrostatic potential on the surface of the
proteins, resulting in different Km values [22]. In the case
of α-IPMS-14CR, although the segment of the protein that
includes the 14 copies of the repeat units is located in the
C-terminal domain, it may come into close proximity
with the active site due to its huge size. The amino acid
composition of the repeat units may also be important.
Since seven of the 19 residues in the repeat unit are
hydrophilic and charged (Figure 5), they could affect the
electrostatic potential on the surface of the enzyme and,
therefore, the enzyme's affinity for its substrates.
The mechanism of l-leucine inhibition was suggested to
be a slow-onset inhibition (time-dependent) [19]. After a
rapid formation of an initial inhibitory complex (leucine
binds to the regulatory domain), isomerization of the
complex occurs, leading to a tightly bound complex. Evi-
dence confirmed that an inhibitory signal is transmitted
through the linker domain to the catalytic domain, as the
Tyr410Phe mutant form of M. tuberculosis α-IPMS is
insensitive to l-leucine feedback inhibition [23]. Muta-
tions that abolish l-leucine feedback inhibition in S. cere-
visiae α-IPMS are clustered around residues surrounding
the l-leucine binding site (amino acids Leu-535, Ala-536,
Val-551, Tyr-554, Ala-558, Ala565 and Ala-567; Figure 5)
[9]. The repeat sequences (residues 575–612) are adjacent
to the residues that surround the l-leucine binding site
(Figure 5). It is possible that α-IPMS-14CR failed to
respond to l-leucine inhibition because the transmission
of the l-leucine inhibition signal, the isomerization step
or both were obstructed by the large segment of 266
amino acid residues, preventing the formation of the tight
complex of enzyme and leucine.
Repetitive DNA sequences can rearrange to increase or
decrease the number of the repetitive elements through
replication "slippage" events [24]. Thus, strains with low
numbers of tandem repeats can evolve to have higher
copy numbers and vice versa. VNTR4155 analysis of 85
clinical strains from Amnatchareon showed that the fre-
quencies of bacteria with 2, 3, 10, 11, 14, 16, 17, 18, 19
and 21 copies of the repeat unit are 74.1, 4.7, 7, 1.1, 2.4,
2.4, 2.4, 2.4, 2.4 and 1.1%, respectively [25]. While most
strains contain two copies, including most of the Beijing
strains, the existence of strains with high copy numbers
suggest that there may be a selective advantage to having
more repeat units in some environments.
Previous studies have shown that leucine auxotrophs
(leuDΔ mutants) of M. bovis BCG and M. tuberculosis are
unable to grow in macrophages and in mice [26,27], sug-
gesting that leucine cannot be obtained in such environ-
ments. Although there is no data on the amino acid
concentrations in M. tuberculosis present in macrophages,
it can be speculated that α-IPMS proteins with high copy
numbers of the repeat may be useful in macrophages.
With a lower Km, α-IPMS can work sufficiently even at low
concentrations of substrate, and with a low Vmax, growth
is only partially affected. Moreover, l-leucine feedback
inhibition may not be necessary in M. tuberculosis when it
is residing in macrophages. Whether VNTR4155 contrib-
Inhibition of His6-α-IPMS activity by l-leucine Figure 4
Inhibition of His6-α-IPMS activity by l-leucine. Activity 
of His6-α-IPMS-2CR and of His6-α-IPMS-14CR in the pres-
ence of 0.1–10.0 mM of l-leucine. Assays were performed as 
described in the Materials and Methods at 37°C, pH 8.5. Each 
point is the average of three assays and the vertical bars rep-
resent the standard deviations.
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utes to the differential survival in these environments is
unknown.
Conclusion
α-IPMS-2CR and α-IPMS-14CR have significantly differ-
ent affinities for the two substrates, α-ketoisovalerate and
acetyl CoA, and respond differently to inhibition by the
enzymatic end-product, l-leucine. The large insertion of
the VNTR (14 copies) likely interferes with the enzyme
structure and function, though it is also possible that α-
IPMS-14CR does not bind l-leucine and, therefore, does
not respond to feedback inhibition. Further work on the
binding of l-leucine to α-IPMS-14CR will clarify this
result.
Methods
Materials
Acetyl CoA, DTNB [5,5'-dithio-bis (2-nitrobenzoic acid);
Ellman's Reagent], α-ketoisovaleric acid and l-leucine
were obtained from Sigma-Aldrich Inc., St. Louis, MO,
USA. All other chemicals were obtained from commercial
sources and were of reagent grade. Restriction enzymes
and T4 DNA ligase were obtained from New England
Biolabs, Bevery, MA, USA. Taq  DNA polymerase was
obtained from Invitrogen, Carlsbad, CA, USA.
Bacterial strains and culture media
Escherichia coli strain DH5α was used for maintaining and
cloning plasmid DNA. E. coli strain BL21 (λDE3) [28] was
used for protein expression. M. tuberculosis isolate number
731, obtained from a pulmonary tuberculosis patient in
Amnatchareon province, Thailand, and the M. tuberculosis
H37Rv strain (laboratory strain: ATCC 25618) were the
sources of the leuA gene with 14 and 2 copies, respectively,
of the 57 bp tandem repeat [25]. E. coli was grown in
Luria-Bertani (LB) medium. M. tuberculosis was grown on
Middlebrook 7H11 agar supplemented with 10% Middle-
brook OADC [Oleic acid Albumin Dextrose Catalase]
Enrichment (Difco BBL).
DNA manipulations
Standard protocols for DNA manipulation, DNA transfor-
mation, DNA sequencing and PCR amplification were
performed as previously described [29,30]. M. tuberculosis
genomic DNA was prepared as previously described [31].
Cloning of the leuA gene containing 14 copies of the 
repeat units by PCR amplification
Primer design: two primers, leu44 (5'-GGA ATT CCA TAT
GAC AAC TTC TGA ATC GCC C-3') and leu66 (5' -CGC
GGA TCC CTA GCG TGC CGC CCG GTT GAC-3') [4],
which flank the 5' and 3' ends of the leuA  gene, were
designed to include NdeI and BamHI recognition sites to
facilitate the cloning of the leuA gene into pET15b (Nova-
Amino acid sequence of α-IPMS containing two copies of the VNTR Figure 5
Amino acid sequence of α-IPMS containing two copies of the VNTR. The N-terminal domain (catalytic domain), resi-
dues 51–368, is colored red. Residues involved in substrate (α-KIV) binding are underlined: D81, H285, H287, N321, E309 and 
G320. The conserved GxGERxG motif (residues 314–320, H379 and Y410), which forms a groove possible for acetyl CoA 
binding, is underlined. Linker domain: subdomain I (residues 369–424) is colored blue; subdomain II (residues 434–490) is 
colored magenta. The C-terminal regulatory domain (residues 491–644) is colored green. The two copies (one copy contains 
19 amino acids, vtiaspaqpgeagrhasdp, at residues 575–612) of the repeat sequence are underlined. The hydrophilic and charged 
residues are in bold. Residues involved in leucine binding are indicated in bold italics: L535, A536, V551, Y554, A565 and A567. 
Mutation of residues G531, G533 and A536 (underlined) abolished feedback inhibition of α-IPMS in S. cerevisiae. The Y410F 
mutant form of M. tuberculosis α-IPMS was insensitive to feedback inhibition.
1 MTTSESPDAY TESFGAHTIV KPAGPPRVGQ PSWNPQRASS MPVNRYRPFA EEVEPIRLRN
61 RTWPDRVIDR APLWCAVDLR DGNQALIDPM SPARKRRMFD LLVRMGYKEI EVGFPSASQT
121 DFDFVREIIE QGAIPDDVTI QVLTQCRPEL IERTFQACSG APRAIVHFYN STSILQRRVV
181 FRANRAEVQA IATDGARKCV EQAAKYPGTQ WRFEYSPESY TGTELEYAKQ VCDAVGEVIA
241 PTPERPIIFN LPATVEMTTP NVYADSIEWM SRNLANRESV ILSLHPHNDR GTAVAAAELG
301 FAAGADRIEG CLFGNGERTG NVCLVTLGLN LFSRGVDPQI DFSNIDEIRR TVEYCNQLPV
361 HERHPYGGDL VYTAFSGSHQ DAINKGLDAM KLDADAADCD VDDMLWQVPY LPIDPRDVGR
421 TYEAVIRVNS QSGKGGVAYI MKTDHGLSLP RRLQIEFSQV IQKIAEGTAG EGGEVSPKEM
481 WDAFAEEYLA PVRPLERIRQ HVDAADDDGG TTSITATVKI NGVETEISGS GNGPLAAFVH
541 ALADVGFDVA VLDYYEHAMS AGDDAQAAAY VEASVTIASP AQPGEAGRHA SDPVTIASPA
601 QPGEAGRHAS DPVTSKTVWG VGIAPSITTA SLRAVVSAVN RAARBMC Microbiology 2009, 9:122 http://www.biomedcentral.com/1471-2180/9/122
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gen). We used 50 μl reaction mixtures containing 50 ng
DNA template, 0.2 mM each dNTP, 1 mM each primer,
1.25 mM MgCl2, 2 units Taq DNA polymerase, 10 mM
Tris-HCl (pH 8.3), 50 mM KCl and 0.1% Tween20 for
PCR. Reactions were denatured at 94°C for 2 min and
then cycled through 30 rounds of denaturation at 94°C
for 30 sec, annealing at 62°C for 2 min, and extension at
72°C for 2 min. These cycles were followed with a final
cycle at 72°C for 10 min.
PCR products from strain 731 were purified using a PCR
purification kit (QIAGEN, Valencia, CA, USA), digested
with  NdeI and BamHI, ligated to compatible sites in
pET15b and transformed into E.  coli  DH5α. Correct
clones were identified by colony-PCR and subsequently
confirmed by restriction enzyme digestion and DNA
sequencing. The PP1 and PP2 primers (PP1: 5'-tac tac gag
cac gcg atg a-3', PP2: 5'-GTG ATT GAC GGT GCG AT-3'),
which flanked the tandem repeats, were used to sequence
the cloned genes. The recombinant plasmids were then
transformed into E. coli BL21 (λDE3).
Protein expression
E. coli BL21 (λDE3) cells harboring the recombinant plas-
mids were grown at 37°C in LB medium supplemented
with 100 μg/ml of ampicillin until the culture reached
mid log phase (~0.3–0.4 OD600). IPTG was added to the
culture to a final concentration of 0.5 mM. The culture
was incubated at 20°C with shaking overnight. The bacte-
rial cells were harvested by centrifugation, washed once
with 50 mM Tris-HCl, pH 7.0, and stored at -70°C until
use.
Protein purification
One milligram of cells (wet weight) from 200 ml of cul-
ture media was resuspended in 1 ml lysis buffer (10 mM
NaH2PO4, 300 mM NaCl, 10 mM imidazole, pH 8.0) and
lysed by sonication. The cell lysate was centrifuged at
10,000 g for 30 min to separate the soluble and insoluble
fractions. Cleared lysate containing the His6-tagged pro-
tein was transferred to a tube containing 0.5 ml of 50%
Ni-NTA agarose (QIAGEN, Valencia, CA, USA) saturated
in lysis buffer. The lysate was mixed with the Ni-NTA resin
and incubated at 4°C for 60 min. The mixture was then
transferred to a 5 ml column, and the flow-through frac-
tion was collected. The column was washed three times
with 5 ml wash buffer (50 mM NaH2PO4, 300 mM NaCl,
20 mM imidazole, pH 8.0). The recombinant protein was
then eluted with 0.5 ml elution buffer (50 mM NaH2PO4,
300 mM NaCl, 250 mM imidazole, pH 8.0), dialyzed
against 50 mM phosphate buffer, pH 7.0, concentrated by
Amicon Ultra centrifugal filter (Millipore) and stored in
50% glycerol at -70°C.
Protein analysis and gel filtration
Protein fractions were analyzed by 10% SDS-PAGE. Pro-
tein concentration was determined by the Lowry method
[32]. Purified recombinant proteins were applied to a
Superdex 200 HR/30 column saturated with 50 mM
sodium phosphate, 150 mM NaCl, pH 7.0 (Amersham
Pharmacia Biotech, column diameter = 2 cm and column
length = 70 cm). A mobility standard curve was con-
structed from standard markers: vitamin B12 (1.355
kDa), cytochrome C (12.4 kDa), carbonic anhydrase
(29.0 kDa), BSA (66.0 kDa), alcohol dehydrogenase (150
kDa) and β-amylase (200 kDa). The column was run at a
flow rate of 0.25 ml/min. The volume of each collected
fraction was 0.5 ml. Fractions containing proteins were
concentrated using an Amicon Ultra centrifugal filter
(Millipore). Glycerol was added to a final concentration
of 50% before storing at -70°C.
Enzyme assay
The procedure for analyzing α-IPMS activity is an end-
point assay using DTNB [5,5'-dithio-bis (2-nitrobenzoic
acid)] to detect the formation of coenzyme A (CoA) at 412
nm (ε = 14140 M-1cm-1) [2]. Reaction mixtures of 150 μl,
containing 50 μmoles Tris-HCl, pH 8.5, 20 μmoles KCl,
0.2 μmoles acetyl CoA and 0.5 μmoles α-ketoisovaleric
acid, were pre-incubated to 37°C for five min. The
enzyme was added in a volume of 100 μl to the reaction
mixtures. After incubating at 37°C for five min, the reac-
tion was stopped with the addition of 0.75 ml absolute
ethanol and 0.5 ml 1 mM DTNB. To determine the opti-
mal pH, enzymes were assayed at pH 5, 6, 7, 8.5 and 9 at
37°C. The enzymes were also assayed at pH 8.5 at 10, 15,
25, 37, 42, 50 and 60°C. The Km and Vmax kinetic param-
eters using the two substrates, α-ketoisovaleric acid and
acetyl CoA, were determined using highly purified pro-
teins (gel filtration fractions) at pH 8.5 and 37°C. In the
assays, the concentration of acetyl CoA was fixed at 0.8
mM, while the concentration of α-ketoisovaleric acid var-
ied from 0.02–2.0 mM or the concentration of α-ketois-
ovaleric acid was fixed at 2 mM, while the concentration
of acetyl CoA were varied from 0.02–1.6 mM. In the prod-
uct inhibition assay, l-leucine was included in the reaction
mixtures at a final concentration of 0.1, 0.2, 0.4, 0.8, 1.0,
5.0 and 10.0 mM.
One unit of enzyme is defined as the amount catalyzing
the formation of 1 μmole CoA per minute [33]. Enzyme
activity (V) is defined as units (of enzyme) per milligram
of protein. The kinetic data were fitted to the Michaelis-
Menten equation by a non-linear least square regression
method. The calculations and graphic results were gener-
ated by Prism 3.03 software. The catalytic constant kcat =
Vmax/[E] (μmol s-1mg-1)/(mol mg-1). The molar concentra-
tions of α-IPMS-2CR and α-IPMS-14CR were 1.426 × 10-8
and 1.084 × 10-8 moles/mg, respectively.BMC Microbiology 2009, 9:122 http://www.biomedcentral.com/1471-2180/9/122
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Additional file 1
Gel filtration profiles of α-IPMS-2CR. Gel filtration of α-IPMS-2CR. 
Material, Superdex 200 HR/30. A, B, C, D, E, F, and G (with arrows) 
refer to the peak positions of blue dextran, amylase, alcohol dehydroge-
nase, BSA, carbonic anhydrase, cytochrome C, and vitamin B12. The 
major peak fractions was dimer protein and the minor peak fractions was 
tetramer protein. Enzyme activity of the minor peak fractions was approx. 
1/3 of the major peak fractions.
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Additional file 2
Gel filtration profiles of α-IPMS-14CR. Gel filtration of α-IPMS-
14CR. Material, Superdex 200 HR/30. A, B, C, D, E, F, and G (with 
arrows) refer to the peak positions of blue dextran, amylase, alcohol dehy-
drogenase, BSA, carbonic anhydrase, cytochrome C, and vitamin B12. 
The major peak fractions was dimer protein and the minor peak fractions 
was monomer protein. Enzyme activity of the minor peak fractions was 
approx. 1/6 of the major peak fractions.
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